{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:55:44Z","timestamp":1791658544182,"version":"4.3.4"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary immunodeficiency diseases (PIDs) are a group of rare inherited disorders affecting the immune system that can be conventionally treated with allogeneic hematopoietic stem cell transplantation and with experimental autologous gene therapy. With both approaches still facing important challenges, gene editing has recently emerged as a potential valuable alternative for the treatment of genetic disorders and within a relatively short period from its initial development, has already entered some landmark clinical trials aimed at tackling several life-threatening diseases. In this review, we discuss the progress made towards the development of gene editing-based therapeutic strategies for PIDs with a special focus on Wiskott - Aldrich syndrome and outline their main challenges as well as future directions with respect to already established treatments.<\/jats:p>","DOI":"10.3389\/fimmu.2022.966084","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:18:11Z","timestamp":1660803491000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Asma","family":"Naseem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-019-00392-3","article-title":"Rare opportunities: CRISPR\/Cas-based therapy development for rare genetic diseases","volume":"23","author":"Papasavva","year":"2019","journal-title":"Mol Diagn Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.24735","article-title":"Introducing rare diseases","volume":"1","author":"Szajner","year":"2013","journal-title":"Rare Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40778-020-00175-1","article-title":"Genome editing for rare diseases","volume":"6","author":"Pradhan","year":"2020","journal-title":"Curr Stem Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Amaya-Uribe","year":"2019","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001075","article-title":"New primary immunodeficiencies 2021 context and future","volume":"33","author":"Demirdag","year":"2021","journal-title":"Curr Opin Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.13.2.133","article-title":"Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea","volume":"13","author":"Aldrich","year":"1954","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1062366","article-title":"Current and emerging treatment options for wiskott-Aldrich syndrome","volume":"11","author":"Worth","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri2724","article-title":"WASP: A key immunological multitasker","volume":"10","author":"Thrasher","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41467-017-01676-0","article-title":"Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.jaci.2017.11.063","article-title":"Neutrophils drive type I interferon production and autoantibodies in patients with wiskott-Aldrich syndrome","volume":"142","author":"Cervantes-Luevano","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132857","article-title":"Wiskott-Aldrich syndrome protein restricts cGAS\/STING activation by dsDNA immune complexes","volume":"5","author":"Piperno","year":"2020","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55547","article-title":"Wiskott Aldrich syndrome protein regulates non-selective autophagy and mitochondrial homeostasis in human myeloid cells","volume":"9","author":"Rivers","year":"2020","journal-title":"Elife"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140814","article-title":"Wiskott-Aldrich syndrome protein deficiency in b cells results in impaired peripheral homeostasis","volume":"112","author":"Meyer-Bahlburg","year":"2008","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110200","article-title":"WASp-deficient b cells play a critical, cell-intrinsic role in triggering autoimmunity","volume":"208","author":"Becker-Herman","year":"2011","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2013.10.006","article-title":"Wiskott-Aldrich syndrome protein deficiency perturbs the homeostasis of b-cell compartment in humans","volume":"50","author":"Castiello","year":"2014","journal-title":"J Autoimmun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.040204","article-title":"The wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling","volume":"96","author":"Calvez","year":"2011","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00047","article-title":"Signal integration during T lymphocyte activation and function: Lessons from the wiskott-Aldrich syndrome","volume":"6","author":"Cotta-de-Almeida","year":"2015","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646715","article-title":"Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity","volume":"47","author":"Rivers","year":"2017","journal-title":"Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.17.9648","article-title":"Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages","volume":"96","author":"Linder","year":"1999","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.2.1135","article-title":"Expression of wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells","volume":"181","author":"Pulecio","year":"2008","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1480","article-title":"Clinical course of patients with WASP gene mutations","volume":"103","author":"Imai","year":"2004","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1592","article-title":"Mutations of the wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl135","article-title":"The expression of wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP)","volume":"19","author":"Konno","year":"2007","journal-title":"Int Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.77.060407.135452","article-title":"Physical mechanisms of signal integration by WASP family proteins","volume":"79","author":"Padrick","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.199570","article-title":"Cellular functions of WASP family proteins at a glance","volume":"130","author":"Alekhina","year":"2017","journal-title":"J Cell Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00161-12","article-title":"Ubiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamics","volume":"32","author":"Reicher","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.31","article-title":"Outcomes following hematopoietic cell transplantation for wiskott-Aldrich syndrome","volume":"47","author":"Shin","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.jaci.2018.06.042","article-title":"One hundred percent survival after transplantation of 34 patients with wiskott-Aldrich syndrome over 20 years","volume":"142","author":"Elfeky","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for wiskott-Aldrich syndrome: C PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014687","article-title":"Hematopoietic stem cell transplantation for wiskott-Aldrich syndrome: An EBMT inborn errors working party analysis","volume":"139","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in wiskott-Aldrich syndrome: Collaborative study of the European society for immunodeficiencies and European group for blood and marrow transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197804272981701","article-title":"Complete correction of the wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation","volume":"298","author":"Parkman","year":"1978","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12026-008-8063-8","article-title":"Results and long-term outcome in 39 patients with wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors","volume":"44","author":"Friedrich","year":"2009","journal-title":"Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat Rev Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for wiskott-Aldrich syndrome\u2013long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of wiskott-Aldrich syndrome: Interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-777136","article-title":"Gene therapy for wiskott-Aldrich syndrome in a severely affected adult","volume":"130","author":"Morris","year":"2017","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","article-title":"Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for wiskott-Aldrich syndrome","volume":"28","author":"Magnani","year":"2022","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR gene therapy: Applications, limitations, and implications for the future","volume":"10","author":"Uddin","year":"2020","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0065-2660(08)60144-3","article-title":"DNA Breakage and repair","volume":"38","author":"Jeggo","year":"1998","journal-title":"Adv Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1126\/science.1078395","article-title":"Chimeric nucleases stimulate gene targeting in human cells","volume":"300","author":"Porteus","year":"2003","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178811","article-title":"Breaking the code of DNA binding specificity of TAL-type III effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat Rev Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1767","article-title":"TALEs of genome targeting","volume":"29","author":"Boch","year":"2011","journal-title":"Nat Biotechnol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.1178817","article-title":"A simple cipher governs DNA recognition by TAL effectors","volume":"326","author":"Moscou","year":"2009","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat Rev Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J Bacteriol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiol (Reading)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol Microbiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.02.057","article-title":"Transit-amplifying cells orchestrate stem cell activity and tissue regeneration","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: Precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage mu gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci Adv"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0509-0","article-title":"Base editors for simultaneous introduction of c-to-T and a-to-G mutations","volume":"38","author":"Sakata","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2916","article-title":"Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease","volume":"32","author":"Kuscu","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"15464","DOI":"10.1038\/ncomms15464","article-title":"CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome","volume":"8","author":"Shin","year":"2017","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.01.466790","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2021","journal-title":"Nat Biotechnol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl9238","article-title":"In vivo prime editing of a metabolic liver disease in mice","volume":"14","author":"Bock","year":"2022","journal-title":"Sci Transl Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01026-y","article-title":"Deletion and replacement of long genomic sequences using prime editing","volume":"40","author":"Jiang","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/hum.2020.185","article-title":"Gene editing for the treatment of primary immunodeficiency diseases","volume":"32","author":"Rai","year":"2021","journal-title":"Hum Gene Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1038\/s41467-020-17552-3","article-title":"Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins","volume":"11","author":"Pavani","year":"2020","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/crispr.2020.0080","article-title":"Optimizing integration and expression of transgenic bruton's tyrosine kinase for CRISPR-Cas9-Mediated gene editing of X-linked agammaglobulinemia","volume":"4","author":"Gray","year":"2021","journal-title":"CRISPR J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of wiskott - Aldrich syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660302","article-title":"Answered and unanswered questions in early-stage viral vector transduction biology and innate primary cell toxicity for ex-vivo gene editing","volume":"12","author":"Dudek","year":"2021","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat Commun"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.02.458799","article-title":"Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing","volume":"458799","author":"Shy","year":"2021","journal-title":"Immunology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2016.06.003","article-title":"Gene correction of iPSCs from a wiskott-Aldrich syndrome patient normalizes the lymphoid developmental and functional defects","volume":"7","author":"Laskowski","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.047","article-title":"Comparison of zinc finger nucleases versus CRISPR-specific nucleases for genome editing of the wiskott-Aldrich syndrome locus","volume":"29","author":"Gutierrez-Guerrero","year":"2018","journal-title":"Hum Gene Ther"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2021.29180.abstracts","article-title":"Preclinical studies for a hematopoietic stem cell gene editing platform to treat wiskott-Aldrich syndrome","author":"Naseem A","year":"2021","journal-title":"Hum Gene Therapy ESGCT 2021."},{"key":"B89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2021.29180.abstracts","article-title":"Preclinical studies for a hematopoietic stem cell gene editing platform to treat wiskott-Aldrich syndrome, in","author":"Naseem","year":"2021","journal-title":"ESGCT."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2647","article-title":"DNA Targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13059-016-1012-2","article-title":"Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR","volume":"17","author":"Haeussler","year":"2016","journal-title":"Genome Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1101\/gr.244293.118","article-title":"Accurate analysis of genuine CRISPR editing events with ampliCan","volume":"29","author":"Labun","year":"2019","journal-title":"Genome Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2020.613252","article-title":"Gene editing and genotoxicity: Targeting the off-targets","volume":"2","author":"Blattner","year":"2020","journal-title":"Front Genome Ed"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2021.618378","article-title":"Gene editing of hematopoietic stem cells: Hopes and hurdles toward clinical translation","volume":"3","author":"Ferrari","year":"2021","journal-title":"Front Genome Ed"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9023","article-title":"Unbiased detection of CRISPR off-targets in vivo using DISCOVER-seq","volume":"364","author":"Wienert","year":"2019","journal-title":"Science"},{"key":"B98","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat Genet"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.06.016","article-title":"Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques","volume":"30","author":"AlJanahi","year":"2022","journal-title":"Mol Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","article-title":"Directed evolution of CRISPR-Cas9 to increase its specificity","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2020.02.023","article-title":"Highly parallel profiling of Cas9 variant specificity","volume":"78","author":"Schmid-Burgk","year":"2020","journal-title":"Mol Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.04.016","article-title":"In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases","volume":"19","author":"Biasco","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B109","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.stem.2018.10.008","article-title":"Cyclosporine h overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells","volume":"23","author":"Petrillo","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"Ravin De","year":"2021","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"108093","DOI":"10.1016\/j.celrep.2020.108093","article-title":"Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells","volume":"32","author":"Shin","year":"2020","journal-title":"Cell Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809958","article-title":"Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives","volume":"11","author":"Naldini","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.02.010","article-title":"Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy","volume":"8","author":"Zonari","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.11.475795","article-title":"Optimized cell culture conditions promote ex-vivo manipulation and expansion of primitive hematopoietic stem cells for therapeutic gene editing","volume":"475795","author":"Rai R","year":"2022","journal-title":"bioRxiv"},{"key":"B117","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24625","article-title":"Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors","volume":"55","author":"Hosel","year":"2012","journal-title":"Hepatology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.07.006","article-title":"Quantification of CpG motifs in rAAV genomes: Avoiding the toll","volume":"28","author":"Wright","year":"2020","journal-title":"Mol Ther"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci Transl Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.1038\/mtm.2016.77","article-title":"The identification of hematopoietic-specific regulatory elements for WASp gene expression","volume":"3","author":"Zhu","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2016.11.001","article-title":"Safe and effective gene therapy for murine wiskott-Aldrich syndrome using an insulated lentiviral vector","volume":"4","author":"Singh","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B124","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.05.015","article-title":"Enhancing lentiviral and alpharetroviral transduction of human hematopoietic stem cells for clinical application","volume":"14","author":"Schott","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.03.005","article-title":"PGE2 and poloxamer synperonic F108 enhance transduction of human HSPCs with a beta-globin lentiviral vector","volume":"13","author":"Masiuk","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2012.203","article-title":"Mechanisms of retroviral integration and mutagenesis","volume":"24","author":"Cavazza","year":"2013","journal-title":"Hum Gene Ther"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61852","article-title":"Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts","volume":"122","author":"Moiani","year":"2012","journal-title":"J Clin Invest"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.10.008","article-title":"Optimization of CRISPR\/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements","volume":"27","author":"Lattanzi","year":"2019","journal-title":"Mol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.966084\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:18:14Z","timestamp":1660803494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.966084\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":129,"alternative-id":["10.3389\/fimmu.2022.966084"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.966084","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"article-number":"966084"}}